
QIAGEN N.V. QGEN
Annual report 2025
added 04-04-2026
QIAGEN N.V. Current Ratio 2011-2026 | QGEN
Annual Current Ratio QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1.88 | 1.94 | 1.85 | 2.02 | 3.36 | 3.58 | 2.66 | 2.73 | 3.72 | 1.55 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.72 | 1.55 | 2.53 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioNano Genomics
BNGO
|
2.52 | $ 1.14 | 0.88 % | $ 6.21 M | ||
|
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
5.26 | $ 16.07 | -0.28 % | $ 173 M | ||
|
Agilent Technologies
A
|
2.01 | $ 116.09 | 0.88 % | $ 35.3 B | ||
|
Aspira Women's Health
AWH
|
0.44 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
3.75 | $ 16.43 | 2.34 % | $ 876 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M | ||
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M | ||
|
Interpace Biosciences
IDXG
|
2.95 | $ 2.23 | -3.26 % | $ 9.87 M | ||
|
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
6.01 | $ 1.38 | 0.74 % | $ 1.84 M | ||
|
Exact Sciences Corporation
EXAS
|
1.69 | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
7.05 | $ 22.86 | -1.17 % | $ 635 M | ||
|
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
1.82 | $ 178.59 | 1.66 % | $ 8.85 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
1.3 | $ 495.8 | 0.46 % | $ 14.3 B | ||
|
Danaher Corporation
DHR
|
5.19 | $ 192.99 | 1.8 % | $ 138 B | ||
|
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | ||
|
Myriad Genetics
MYGN
|
2.09 | $ 4.51 | 3.79 % | $ 418 M | ||
|
NeoGenomics
NEO
|
2.6 | $ 7.89 | 2.54 % | $ 1.01 B | ||
|
Illumina
ILMN
|
6.69 | $ 123.69 | 2.28 % | $ 19.7 B | ||
|
Fulgent Genetics
FLGT
|
13.4 | $ 15.14 | 4.92 % | $ 458 M | ||
|
Guardant Health
GH
|
0.953 | $ 79.27 | 0.85 % | $ 9.94 B | ||
|
Anixa Biosciences
ANIX
|
7.55 | $ 2.8 | 4.08 % | $ 90.9 K | ||
|
Biomerica
BMRA
|
3.23 | $ 2.07 | -3.5 % | $ 4.75 M | ||
|
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
1.69 | $ 28.38 | 0.26 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
2.29 | $ 109.1 | 2.14 % | $ 9 B | ||
|
Senseonics Holdings
SENS
|
1.94 | $ 6.65 | -0.45 % | $ 277 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 262.3 | 0.53 % | $ 21.8 B | ||
|
Natera
NTRA
|
2.02 | $ 197.28 | 2.2 % | $ 19.4 B | ||
|
Celcuity
CELC
|
1.27 | $ 118.07 | 0.79 % | $ 5.52 B | ||
|
Lantheus Holdings
LNTH
|
1.96 | $ 80.94 | 0.43 % | $ 5.46 B | ||
|
Soleno Therapeutics
SLNO
|
4.96 | $ 52.65 | 0.04 % | $ 2.68 B | ||
|
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | ||
|
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 190.76 | -0.4 % | $ 21.2 B | ||
|
Neogen Corporation
NEOG
|
2.51 | $ 9.15 | -2.81 % | $ 1.98 B | ||
|
ENDRA Life Sciences
NDRA
|
2.42 | $ 5.0 | 1.21 % | $ 3.94 M | ||
|
Neuronetics
STIM
|
1.23 | $ 1.4 | 3.33 % | $ 92.3 M |